Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02799733
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
T29 | TRI166 (BIFUNCTIONAL BORONATE INHIBITOR) | H | 1A3B | 0.74 | |
STB | 4-SULFONAMIDE-[4-(THIOMETHYLAMINOBUTANE)]BENZAMIDE | A | 1OKN | 0.74 | |
ETS | (4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO- 6-METHYL-4H-THIENO(2,3-B)THIOPYRAN- 2-SULFONAMIDE-7,7-DIOXIDE | A | 1CIL | 0.71 | |
TST | 4-METHYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PENTANOIC ACID | A | 1J4I | 0.83 | |
CRJ | N-(1-CYANOCYCLOPROPYL)-3-({[(2S)- 5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)- N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4- FLUOROPHENYL)ETHYL]-L-ALANINAMIDE | A,B | 2FQ9 | 0.73 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1XA7 | 0.7 | |
PG1 | PENICILLIN G ACYL-SERINE | A | 2IWC | 0.7 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1MWT | 0.7 | |
3CC | N-[(2R)-5-(aminosulfonyl)-2,3-dihydro- 1H-inden-2-yl]-2-propylpentanamide | A | 2QO8 | 0.79 | |
IZD | ISOTHIAZOLIDINONE ANALOG | A | 2CM7 | 0.78 | |
SH1 | N-[(2-PHENYLETHYL)SULFONYL]-D-SERYL- N-[(1S)-4-[(DIAMINOMETHYLENE)AMINO]- 1-(HYDROXYMETHYL)BUTYL]-L-ALANINAMIDE | U | 1W14 | 0.71 | |
VS1 | 3-[[N-[MORPHOLIN-N-YL]-CARBONYL]- PHENYLALANINYL-AMINO]-5- PHENYL- PENTANE-1-SULFONYLBENZENE | A | 2P86 | 0.7 | |
VS1 | 3-[[N-[MORPHOLIN-N-YL]-CARBONYL]- PHENYLALANINYL-AMINO]-5- PHENYL- PENTANE-1-SULFONYLBENZENE | A,B,C | 1F29 | 0.7 | |
M25 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | A,B | 2NMX | 0.81 | |
M25 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | A | 2NNS | 0.81 | |
4MC | (Z)-N-(5-GUANIDINO-1-OXO-1-(5-PHENYL- 1-(PHENYLSULFONYL)PENT-1-EN-3-YLAMINO)PENTAN- 2-YL)-4-METHYLPIPERAZINE-1-CARBOXAMIDE | A,C | 2EFM | 0.74 | |
TP2 | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4D | 0.89 | |
TP2 | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4C | 0.89 | |
G0G | N,N'-(3S,4S)-PYRROLIDINE-3,4-DIYLBIS(N- BENZYLBENZENESULFONAMIDE) | A,B | 2PQZ | 0.71 | |
EG1 | AMINOMETHYLENECARBONYLAMINODI(ETHYLOXY)ETHYLAMINOCARBONYLBENZENESULFONAMIDE | A | 1CNW | 0.7 | |
F21 | (3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN- 4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE | A,B | 2G72 | 0.71 | |
F21 | (3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN- 4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE | A,B | 2OPB | 0.71 | |
MQQ | N-[(1S)-1-[({(1S)-3-PHENYL-1-[2- (PHENYLSULFONYL)ETHYL]PROPYL}AMINO)CARBONYL]- 3-(PHENYLSULFONYL)PROPYL]MORPHOLINE- 4-CARBOXAMIDE | A | 2G6D | 0.73 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 1PI4 | 0.71 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 2FFY | 0.71 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 1MY8 | 0.71 | |
F20 | N-BENZOYL-L-PHENYLALANYL-4-[(5S)- 1,1-DIOXIDO-3-OXOISOTHIAZOLIDIN- 5-YL]-L-PHENYLALANINAMIDE | A | 2CMA | 0.7 | |
BCQ | N-[(1R)-1-[({[(5S)-3,5-DIMETHYL- 2,5-DIHYDROISOXAZOL-4-YL]METHYL}SULFONYL)METHYL]- 2-OXO-2-({(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}AMINO)ETHYL]MORPHOLINE- 4-CARBOXAMIDE | A | 2FYE | 0.7 | |
RA8 | N-(BENZYLSULFONYL)-L-LEUCYL-N-(4- {[AMINO(IMINO)METHYL]AMINO}BUTYL)- L-PROLINAMIDE | H,I | 1YPL | 0.76 | |
DI5 | AC-(D)PHE-PRO-BOROHOMOORNITHINE- OH | H | 1LHG | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A | 1GHP | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A | 1PWC | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A | 1IYQ | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A | 1FQG | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2J8Y | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2JBF | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A | 2EX8 | 0.71 | |
NFT | N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'- (AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2- TRIFLUOROETHYL}-L-LEUCINAMIDE | A | 1VSN | 0.74 | |
GSB | S-BENZYL-GLUTATHIONE | A,B,C,D | 1FRO | 0.72 | |
GSB | S-BENZYL-GLUTATHIONE | A,B,C,D | 1GUH | 0.72 | |
MZ1 | N~2~-ACETYL-N-[(1S,2R)-1-BENZYL- 2-HYDROXY-3-{(2-THIENYLMETHYL)[(2,4,5- TRIFLUOROPHENYL)SULFONYL]AMINO}PROPYL]- L-ALANINAMIDE | A,B | 2QHY | 0.72 | |
C71 | N-[4-(AMINOMETHYL)-1,1-DIOXIDOTETRAHYDRO- 2H-THIOPYRAN-4-YL]-3-(1-METHYLCYCLOPENTYL)- N~2~-[(1E)-N-(PHENYLSULFONYL)ETHANIMIDOYL]- L-ALANINAMIDE | A,B | 2FRQ | 0.77 | |
SUB | 3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PROPIONIC ACID ETHYL ESTER | A | 1J4H | 0.76 | |
SAB | 4-SULFONAMIDE-[1-(4-AMINOBUTANE)]BENZAMIDE | A | 1OKM | 0.73 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1JK3 | 0.75 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1MMB | 0.75 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 2RJQ | 0.75 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1RM8 | 0.75 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 2J83 | 0.75 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 1DTH | 0.75 | |
R56 | 5-OXO-6-PHENYLMETHANESULFONYLAMINO- HEXAHYDRO-THIAZOLO[3,2-A]PYRIDINE- 3-CARBOXYLIC ACID (3-GUANIDINO- PROPYL)-AMIDE | F | 1BHX | 0.76 | |
C1P | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B,C,D | 3BWK | 0.73 | |
C1P | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B | 1NPZ | 0.73 | |
JT5 | N~2~-(biphenyl-4-ylsulfonyl)-N- hydroxy-N~2~-(2-hydroxyethyl)glycinamide | A | 2JT5 | 0.71 | |
TCK | N-[(1S)-5-amino-1-(chloroacetyl)pentyl]- 4-methylbenzenesulfonamide | A | 1ARC | 0.7 | |
GSJ | 1-PYRROLIDINEACETAMIDE, 3-[[(6- CHLORO-2-NAPHTHALENYL)SULFONYL]AMINO]- ALPHA-METHYL-N-(1-METHYLETHYL)- N-[2-[(METHYLSULFONYL)AMINO]ETHYL]- 2-OXO-, (ALPHAS,3S)- | A | 2J4I | 0.73 | |
DI4 | AC-(D)PHE-PRO-BOROHOMOLYS-OH | H | 1LHF | 0.71 | |
MIU | N-{(1S)-1-{[4-(3-AMINOPROPYL)PIPERAZIN- 1-YL]CARBONYL}-4-[(DIAMINOMETHYLENE)AMINO]BUTYL}- 3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | H | 1W7G | 0.72 | |
YDP | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A | 2ZGA | 0.75 | |
YDP | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A,B | 3CKT | 0.75 | |
HS4 | N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide | A | 3F17 | 0.72 | |
BSB | N-BENZYL-4-SULFAMOYL-BENZAMIDE | A | 1G4O | 0.7 | |
TI1 | [2(R,S)-2-SULFANYLHEPTANOYL]-PHE- ALA | A | 1R1I | 0.71 | |
TI1 | [2(R,S)-2-SULFANYLHEPTANOYL]-PHE- ALA | A | 1QF1 | 0.71 | |
DI2 | AC-(D)PHE-PRO-BOROLYS-OH | H | 1LHD | 0.71 | |
D1R | NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]- N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}- L-PHENYLALANINAMIDE | A | 2P7U | 0.74 | |
D1R | NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]- N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}- L-PHENYLALANINAMIDE | A,C | 2OZ2 | 0.74 |